Discovery, Innovation, Growth
Park Square has placed David Moller, MD, as Chief Scientific Officer at Poxel SA.
POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic...…
Park Square is pleased to announce the placement of Jerome Riebman, M.D., as Chief Medical Officer at Aziyo Biologics, Inc. Aziyo...
Park Square has placed Mark Massaro as Chief Financial Officer at ArcherDX, Inc.
ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized...…
Park Square has placed Mark Namchuk, Ph.D. as executive director of therapeutics translation at Harvard Medical School.
Harvard Medical School has named Mark Namchuk, PhD, a former pharmaceutical R&D executive with a background in immunology and bioorganic...…
Park Square has placed Jeffrey Goldberg as Chief Executive Officer and Director of Immunitas Therapeutics.
Immunitas Therapeutics (“Immunitas”), an innovative single cell genomics discovery platform company focused on developing breakthrough...…
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
